Publications January 26, 2021 Publication 01 ProteoDesign rebrands as Splice Bio to develop novel gene therapies based on its proprietary intein… Antonio Solano 0 Love0
Press Release January 21, 2021 Splice Bio appoints Jean-Philippe Combal as Chairman of the Board of Directors BARCELONA, January 21, 2021 – Splice Bio, a gene therapy company based on technology developed… Antonio Solano 0 Love0
Press Release December 10, 2020 Splice Bio announces research funding by Cystic Fibrosis Foundation to develop novel AAV vectors BARCELONA, December 10, 2020 – Splice Bio, a biotech company based on technology developed in… Antonio Solano 0 Love0
Press Release September 15, 2020 ProteoDesign announces new Investment led by Ysios Capital and rebrands as Splice Bio ProteoDesign rebrands as Splice Bio to develop novel gene therapies based on its proprietary intein… Antonio Solano 0 Love0
Recent Comments